SODIUM NITRITE
| Brand name | SODIUM NITRITE |
|---|---|
| Active ingredient | SODIUM NITRITE |
| Strength | 300MG/10ML (30MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | February 2012 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8568793 | December 2031 | substance, product |
| 9687506 | February 2030 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.